Literature DB >> 19411816

Predictors of intra-operative parathyroid hormone decline in subjects operated for primary hyperparathyroidism by minimally invasive parathyroidectomy.

M-H Gannagé-Yared1, B Abboud, M Amm-Azar, A Saab, S Khalife, G Halaby, C Atallah, R Medlej, S Jambart.   

Abstract

BACKGROUND: The predictors of intra-operative PTH (IOPTH) decline during minimally invasive parathyroidectomy (MIP) for primary hyperparathyroidism have been but poorly studied.
MATERIALS AND METHODS: This retrospective study included 108 patients who underwent MIP for a single adenoma. Serum calcium and phosphorus were measured before surgery and 1 day post-operatively. IOPTH was measured before (intra-operative preincision or PTHt0) and 10 min after removal of the adenoma (PTHt10). The Modification of Diet in Renal Disease (MDRD) equation was used to estimate the glomerular filtration rate. The weight of the adenoma was assessed in all the subjects.
RESULTS: The sex ratio female/male was 5.37 with a mean age of 57.3 yr. The mean pre- and postoperative values were for calcium 2.80 and 2.19 mmol/l, respectively (p<0.0001) and for phosphorus 0.90 and 1.16 mmol/l, respectively (p<0.0001). The PTH dropped from a mean value of 184.8 to 50.8 pg/ml 10 min after adenoma resection with a mean drop of 69.7%. Thirteen patients (12%) did not achieve a PTH fall of more than 50%. In a bivariate analysis, age, an MDRD<60 ml/min and weight of adenoma were inversely associated with IOPTH fall (p=0.009, p=0.004, and p<0.001, respectively) while gender, body mass index, hypertension, diabetes, pre-operative phosphorus and calcium had no significant effects. In the multivariate analysis, age, weight of adenoma, and MDRD were still independent negative predictors of the IOPTH fall (p=0.01, p=0.018, and p<0.001, respectively).
CONCLUSION: Our results suggest that during MIP the presence of a parathyroid adenoma with a high weight, in an elderly subject or in a subject with altered renal function, will result in a lesser degree of IOPTH fall.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411816     DOI: 10.1007/BF03345707

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  41 in total

1.  The predictive value of laboratory findings in patients with primary hyperparathyroidism.

Authors:  Géza Mózes; Kathleen J Curlee; Charles M Rowland; Jon A van Heerden; Geoffrey B Thompson; Clive S Grant; David R Farley
Journal:  J Am Coll Surg       Date:  2002-02       Impact factor: 6.113

2.  A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable?

Authors:  Herbert Chen; Eberhard Mack; James R Starling
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

3.  A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure.

Authors:  M R John; W G Goodman; P Gao; T L Cantor; I B Salusky; H Jüppner
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

4.  Rapid intraoperative parathyroid hormone assay--more than just a comfort measure.

Authors:  F Hanif; J C Coffey; L Romics; K O'Sullivan; F Aftab; H P Redmond
Journal:  World J Surg       Date:  2006-02       Impact factor: 3.352

5.  Does intraoperative quick parathyroid hormone assay improve the results of parathyroidectomy?

Authors:  Daishu Miura; Nobuyuki Wada; Cumhur Arici; Eugene Morita; Quan-Yang Duh; Orlo H Clark
Journal:  World J Surg       Date:  2002-04-30       Impact factor: 3.352

6.  The impact of minimally invasive parathyroidectomy on the way endocrinologists treat primary hyperparathyroidism.

Authors:  Scott F Gallagher; Daphne W Denham; Michel M Murr; James G Norman
Journal:  Surgery       Date:  2003-12       Impact factor: 3.982

Review 7.  Rapid intraoperative immunoassay of parathyroid hormone and other hormones: a new paradigm for point-of-care testing.

Authors:  Lori J Sokoll; Frank H Wians; Alan T Remaley
Journal:  Clin Chem       Date:  2004-04-29       Impact factor: 8.327

Review 8.  Minimal-access/minimally invasive parathyroidectomy for primary hyperparathyroidism.

Authors:  F Fausto Palazzo; Leigh W Delbridge
Journal:  Surg Clin North Am       Date:  2004-06       Impact factor: 2.741

9.  The relationship between adenoma weight and intact (1-84) parathyroid hormone level in primary hyperparathyroidism.

Authors:  J G Williams; M H Wheeler; J P Aston; R C Brown; J S Woodhead
Journal:  Am J Surg       Date:  1992-03       Impact factor: 2.565

10.  Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism.

Authors:  Neşe Ozbey; Yeşim Erbil; Evin Ademoğlu; Selçuk Ozarmağan; Umut Barbaros; Alp Bozbora
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

View more
  5 in total

1.  The impact of vitamin D status and tumor size on the intraoperative parathyroid hormone dynamics in patients with symptomatic primary hyperparathyroidism.

Authors:  Gaurav Agarwal; Dhalapathy Sadacharan; Pooja Ramakant; Manoj Shukla; Saroj K Mishra
Journal:  Surg Today       Date:  2012-01-05       Impact factor: 2.549

2.  Is intraoperative parathyroid hormone testing in patients with renal insufficiency undergoing parathyroidectomy for primary hyperparathyroidism accurate?

Authors:  Jonathan A Sohn; Sarah C Oltmann; David F Schneider; Rebecca S Sippel; Herbert Chen; Dawn M Elfenbein
Journal:  Am J Surg       Date:  2014-12-17       Impact factor: 2.565

3.  Factors that influence parathyroid hormone half-life: determining if new intraoperative criteria are needed.

Authors:  Andrew J Leiker; Tina W F Yen; Dan C Eastwood; Kara M Doffek; Aniko Szabo; Douglas B Evans; Tracy S Wang
Journal:  JAMA Surg       Date:  2013-07       Impact factor: 14.766

4.  Justified follow-up: a final intraoperative parathyroid hormone (ioPTH) Over 40 pg/mL is associated with an increased risk of persistence and recurrence in primary hyperparathyroidism.

Authors:  Mohammad H Rajaei; Alex M Bentz; David F Schneider; Rebecca S Sippel; Herbert Chen; Sarah C Oltmann
Journal:  Ann Surg Oncol       Date:  2014-09-06       Impact factor: 5.344

5.  Comparison between Second- and Third-Generation PTH Assays during Minimally Invasive Parathyroidectomy (MIP).

Authors:  Marie-Hélène Gannagé-Yared; Nada Younès; Anne-Sophie Azzi; Ghassan Sleilaty
Journal:  Int J Endocrinol       Date:  2020-03-16       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.